Safety of Noncardiac Surgery in Patients With Hypertrophic Obstructive Cardiomyopathy at a Tertiary Care Center

David W Barbara1, Joseph A Hyder1, Travis L Behrend1

  • 1Department of Anesthesiology, Mayo Clinic College of Medicine, Rochester, MN.

Insights

Patients with hypertrophic obstructive cardiomyopathy (HOCM) can undergo non-cardiac surgery (NCS) safely at experienced centers. While mortality is low, severe preoperative symptoms increase the risk of worsening heart failure post-surgery.

Area of Science:

  • Cardiology
  • Anesthesiology
  • Cardiovascular Surgery

Background:

  • Hypertrophic obstructive cardiomyopathy (HOCM) presents unique challenges for non-cardiac surgery (NCS).
  • Perioperative management and outcomes for HOCM patients undergoing NCS require careful consideration.

Purpose of the Study:

  • To review perioperative management strategies for patients with HOCM undergoing NCS.
  • To quantify postoperative mortality and the incidence of worsening heart failure in this population.

Main Methods:

  • Retrospective review of 57 adult patients with HOCM who underwent 96 NCS procedures at a single tertiary care center.
  • Data collected included perioperative management, mortality, and heart failure exacerbation.

Main Results:

  • The 30-day mortality rate was 3% (3 patients), with no deaths attributed to cardiac causes.
  • Emergency surgery was significantly associated with increased mortality (p = 0.0002).
  • Worsening heart failure was significantly associated with higher preoperative New York Heart Association functional class (p = 0.0008).

Conclusions:

  • Non-cardiac surgery can be performed safely in HOCM patients at specialized multidisciplinary centers.
  • The observed mortality rate was lower than reported in many previous studies.
  • Patients with more severe preoperative cardiac symptoms are at higher risk for postoperative heart failure complications.
Abstract

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
424
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
687
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
621
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
746
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
796
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
452